PURE Bioscience (OTCMKTS:PURE – Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $0.07 and traded as high as $0.0815. PURE Bioscience shares last traded at $0.0752, with a volume of 34,455 shares.
PURE Bioscience Stock Performance
The stock’s 50-day simple moving average is $0.07 and its 200 day simple moving average is $0.07. The company has a market capitalization of $8.85 million, a PE ratio of -2.27 and a beta of 0.33.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products based on its proprietary silver dihydrogen citrate (SDC) technology. SDC is designed to provide broad-spectrum antimicrobial activity while serving as the active ingredient in disinfecting, sanitizing, and hygiene formulations.
The company’s product portfolio has included PURE-branded solutions for hard-surface disinfection and sanitation, as well as applications in food safety, commercial and industrial settings, healthcare, and other environments where microbial control is important.
Featured Stories
- Five stocks we like better than PURE Bioscience
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
